The Combination of Dexamethasone and Ruxolitinib Synergistically Attenuates Disease Manifestations in a Preclinical Model of Hemophagocytic Lymphohistiocytosis
Blood (2019) 134 (Supplement_1): 81.
Currently there are no citedby results. Try again later.
